Crizotinib

Results: 74



#Item
105-AUG:10 LUNG ACCRUAL REPORT - Open and Recently Closed Studies SWOG/ Support STUDY

05-AUG:10 LUNG ACCRUAL REPORT - Open and Recently Closed Studies SWOG/ Support STUDY

Add to Reading List

Source URL: www.swogstat.org

Language: English - Date: 2016-08-19 21:10:12
2Blood Testing for EML4-ALK Fusion Transcripts in Non-Small Cell Lung Cancer Patients by ddPCR: A CLIA Lab Experience Hestia Mellert, PhD  April 17th, 2016

Blood Testing for EML4-ALK Fusion Transcripts in Non-Small Cell Lung Cancer Patients by ddPCR: A CLIA Lab Experience Hestia Mellert, PhD April 17th, 2016

Add to Reading List

Source URL: www.biodesix.com

Language: English - Date: 2016-05-02 01:40:22
3th  6 Meeting of the European Research Initiative on ALK-related Malignancies

th 6 Meeting of the European Research Initiative on ALK-related Malignancies

Add to Reading List

Source URL: erialcl.net

Language: English - Date: 2015-09-30 10:24:57
4Microsoft PowerPoint - Corporate Presentation May 2013

Microsoft PowerPoint - Corporate Presentation May 2013

Add to Reading List

Source URL: erialcl.net

Language: English - Date: 2015-09-29 07:01:25
53rd Meeting of the European Research Initiative on ALCL Punting on the River Cam with the chapel of King’s College in the background

3rd Meeting of the European Research Initiative on ALCL Punting on the River Cam with the chapel of King’s College in the background

Add to Reading List

Source URL: erialcl.net

Language: English - Date: 2015-09-29 07:00:59
6Early Stage researcher (ESR) PhD Projects ESR 1 Investigation of the nuclear functions of ALK Duration: 3 years Start: before August 2016

Early Stage researcher (ESR) PhD Projects ESR 1 Investigation of the nuclear functions of ALK Duration: 3 years Start: before August 2016

Add to Reading List

Source URL: alkatras.erialcl.net

Language: English - Date: 2016-04-15 08:51:39
7Open Up More Treatment Possibilities For Your Patients About FoundationOne® FoundationOne is a validated comprehensive Genomic Profile that interrogates the entire coding sequence of 315 cancer-related genes plus selec

Open Up More Treatment Possibilities For Your Patients About FoundationOne® FoundationOne is a validated comprehensive Genomic Profile that interrogates the entire coding sequence of 315 cancer-related genes plus selec

Add to Reading List

Source URL: www.foundationmedicine.com

Language: English - Date: 2015-07-29 10:38:28
8Phase (Ph) 1/2a study of TSR-011, a potent inhibitor of ALK and TRK, in advanced solid tumors including crizotinib-resistant ALK positive non-small cell lung cancer PosterHendrik-Tobias Arkenau,1 Jasgit C. Sachdev

Phase (Ph) 1/2a study of TSR-011, a potent inhibitor of ALK and TRK, in advanced solid tumors including crizotinib-resistant ALK positive non-small cell lung cancer PosterHendrik-Tobias Arkenau,1 Jasgit C. Sachdev

Add to Reading List

Source URL: www.tesarobio.com

Language: English - Date: 2015-06-03 16:42:55
    9SPECIAL AUTHORIZATION REQUEST FOR COVERAGE OF HIGH COST CANCER DRUGS (Filgrastim, Capecitabine, Imatinib, Dasatinib, Erolotinib, Sunitinib, Pazopanib, Fludarabine, Sorafenib, Crizotinib, Tretinoin, Nilotinib, Temozolomid

    SPECIAL AUTHORIZATION REQUEST FOR COVERAGE OF HIGH COST CANCER DRUGS (Filgrastim, Capecitabine, Imatinib, Dasatinib, Erolotinib, Sunitinib, Pazopanib, Fludarabine, Sorafenib, Crizotinib, Tretinoin, Nilotinib, Temozolomid

    Add to Reading List

    Source URL: www.gov.pe.ca

    Language: English - Date: 2015-04-28 07:44:05
    10Correlation of plasma crizotinib trough concentration with adverse events in patients with anaplastic lymphoma kinase positive non-small-cell lung cancer

    Correlation of plasma crizotinib trough concentration with adverse events in patients with anaplastic lymphoma kinase positive non-small-cell lung cancer

    Add to Reading List

    Source URL: www.jphcs.net

    Language: English